Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1599 results found

2024 ∙ Sayed, A. A.

Evaluating COVID-19 vaccine acceptance among parents in Saudi Arabia: a systematic review examining attitudes, hesitancy, and intentions

  • Eastern Mediterranean
  • Saudi Arabia
  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Hu, Y. H. Ding, Y. Li, L. W. Cheng, J. Cai, Y. H.

Evaluation of vaccine effectiveness of mRNA COVID-19 vaccines in children: a systematic review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Harandi, H. Fallahtafti, P. Karimi, A. Hashemi, S. M. Mahalleh, M. Ashouri, M. Salehi, M. A. Hoveidaei, A.

Examining the immunological responses to COVID-19 vaccination in multiple myeloma patients: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Razai, M. S. Mansour, R. Ravindran, P. Freeman, S. Mason-Apps, C. Morris, J. Majeed, A. Ussher, M. Hargreaves, S. Oakeshott, P.

Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review

  • Pregnant women
  • Influenza
  • Pertussis
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Ahmad, S. J. Degiannis, J. R. Borucki, J. Pouwels, S. Rawaf, D. L. Lala, A. Whiteley, G. S. Head, M. Simpson, A. Archid, R. Ahmed, A. R. Soler, J. A. Wichmann, D. Thangavelu, M. Abdulmajed, M. Elmousili, M. Lin, Y. R. Gelber, E. Exadaktylos, A. K.

Fatality Rates After Infection With the Omicron Variant (B.1.1.529): How Deadly has it been? A Systematic Review and Meta-Analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ SeyedAlinaghi, S. Pashapouryeganeh, A. Dehghani, S. Mirzapour, P. Abbaspour, F. Afroughi, F. Rahimzadeh, P. Najafi, M. Ghasemi, H. Mozafari, N. Soltanali, Z. Mehraeen, E.

Feasibility and Effectiveness of Vaccines for COVID-19: An Umbrella Review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
  • Safety
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Angeletti, P. M. Marchi, S. Trombetta, C. M. Altobelli, E.

Flu vaccine administration in the period before SARS-CoV-2 infection and its outcomes: An umbrella review

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Abate, B. B. Tilahun, B. D. Yayeh, B. M.

Global COVID-19 vaccine acceptance level and its determinants: an umbrella review

  • All age groups
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Law, M. C. Chiu, P. K. F.

Global COVID-19 vaccine hesitancy among elderly: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Abuawwad, M. T. Taha, M. J. J. Taha, A. J. Kozaa, Y. A. Falah, O. Abuawwad, I. T. Hammad, E. M. Mahmoud, A. A. Aladawi, M. Serhan, H. A.

Guillain-Barré syndrome after COVID-19 vaccination: A systematic review and analysis of case reports

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...